Exploring CAR T-cell therapy for aggressive follicular lymphoma

by Olivia Dimmer,Northwestern UniversityORR by best overall response per IRC assessment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02986-9CAR T-cell therapy is an effecti

Updated on: August 01,2024 0

Exploring CAR T-cell therapy for aggressive follicular lymphoma

by Olivia Dimmer,Northwestern UniversityORR by best overall response per IRC assessment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02986-9CAR T-cell therapy is an effecti

Updated on:August 01,2024 0

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on: April 07,2024 19

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on:April 07,2024 19

One protein is key to the spread of lung cancer: New study finds a way to stop it

by Tulane UniversityCredit: Pixabay/CC0 Public DomainA new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its

Updated on: May 20,2024 4

One protein is key to the spread of lung cancer: New study finds a way to stop it

by Tulane UniversityCredit: Pixabay/CC0 Public DomainA new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its

Updated on:May 20,2024 4

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on: August 27,2024 0

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on:August 27,2024 0

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on: January 15,2024 12

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on:January 15,2024 12

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on: March 01,2024 10

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on:March 01,2024 10

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on: May 23,2024 6

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on:May 23,2024 6

Immune system boost could prevent lung cancer

by Sara Rimer,Boston UniversityIn this microscopic image of precancerous lung tissue, the hot pink cells are dividing faster than in normal lung tissue. Credit: Beane, et al.,Nature Commun

Updated on: April 18,2024 19

Immune system boost could prevent lung cancer

by Sara Rimer,Boston UniversityIn this microscopic image of precancerous lung tissue, the hot pink cells are dividing faster than in normal lung tissue. Credit: Beane, et al.,Nature Commun

Updated on:April 18,2024 19

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on: September 10,2024 0

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on:September 10,2024 0

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on: January 02,2024 10

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on:January 02,2024 10

Study reveals how fatty liver promotes colorectal cancer spread

by Cedars-Sinai Medical CenterGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.04.013Investigators at Cedars-Sinai Cancer found that fatty liver, a condition

Updated on: February 01,2024 13

Study reveals how fatty liver promotes colorectal cancer spread

by Cedars-Sinai Medical CenterGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.04.013Investigators at Cedars-Sinai Cancer found that fatty liver, a condition

Updated on:February 01,2024 13

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for

Updated on: January 07,2024 10

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for

Updated on:January 07,2024 10